Table 2 |
|||||
|
Bilateral Data Summary – CRS and Survey ($US 000's, 2000) |
|||||
|
Country |
CRS Malaria Control Estimate [36] |
Survey Response |
Total Malaria Funding (Survey responses used if available) |
% of Total Malaria Spending |
% of GDP Spent on Malaria [37] |
|
|
|||||
|
Australia |
133 |
217 |
217 |
0.4% |
0.00004% |
|
Austria |
0 |
0 |
0 |
0.0% |
0.00000% |
|
Belgium |
952 |
Failed To Reply |
952 |
1.7% |
0.00035% |
|
Canada |
0 |
Failed to Reply |
0 |
0.0% |
0.00000% |
|
Denmark |
0 |
Refused |
0 |
0.0% |
0.00000% |
|
Commission of the European Communities |
0 |
0 |
0 |
0.0% |
n/a |
|
Finland |
0 |
0 |
0 |
0.0% |
0.00000% |
|
France |
4571 |
Failed To Reply |
4571 |
8.3% |
0.00033% |
|
Germany |
1,000 |
3,000 |
3,000 |
5.4% |
0.00015% |
|
Greece |
0 |
Failed To Reply |
0 |
0.0% |
0.00000% |
|
Ireland |
50 |
250 |
250 |
0.5% |
0.00023% |
|
Italy |
6,500 |
Failed To Reply |
6,500 |
11.8% |
0.00046% |
|
Japan |
0 |
Failed To Reply |
0 |
0.0% |
0.00000% |
|
Luxembourg |
0 |
Failed To Reply |
0 |
0.0% |
0.00000% |
|
Netherlands |
1,860 |
Failed To Reply |
1,860 |
3.4% |
0.00043% |
|
New Zealand |
0 |
Failed to Reply |
0 |
0.0% |
0.00000% |
|
Norway |
28 |
0 |
0 |
0.0% |
0.00000% |
|
Portugal |
0 |
Failed To Reply |
0 |
0.0% |
0.00000% |
|
Spain |
864 |
Failed To Reply |
864 |
1.6% |
0.00011% |
|
Sweden |
0 |
0 |
0 |
0.0% |
0.00000% |
|
Switzerland |
0 |
Refused |
0 |
0.0% |
0.00000% |
|
United Kingdom |
6,000 |
10,000 |
10,000 |
18.1% |
0.00070% |
|
United States |
28,000 |
27,000 |
27,000 |
48.9% |
0.00027% |
|
TOTALS |
55214 |
100% |
.00023% |
||
|
|
|||||
|
Narasimhan and Attaran Malaria Journal 2003 2:8 doi:10.1186/1475-2875-2-8 |
|||||
